Compare Accretion Nutrav with Similar Stocks
Total Returns (Price + Dividend) 
Accretion Nutrav for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
Announcements 
Board Meeting Intimation for Board Meeting Intimation For Consider And Approve Audited Financial Results For The Year Ended On 31St March 2026
01-May-2026 | Source : BSEAccretion Nutraveda Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2026 inter alia to consider and approve Audited Financial Result for the Year Ended on 31st March 2026
Clarification On Price Movement
30-Apr-2026 | Source : BSEPlease find enclosed herewith clarification Letter on price movement
Clarification sought from Accretion Nutraveda Ltd
29-Apr-2026 | Source : BSEThe Exchange has sought clarification from Accretion Nutraveda Ltd on April 29 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.
The reply is awaited.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Feb 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 1 FIIs (6.04%)
Ankurkumar Shantilal Patel (14.7%)
Unicorn Fund (6.51%)
10.48%
Half Yearly Results Snapshot (Standalone) - Mar'26
Growth in half year ended Mar 2026 is 38.98% vs 29.59% in Sep 2025
Growth in half year ended Mar 2026 is 15.45% vs 35.47% in Sep 2025
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 110.00% vs 219.36% in Mar 2025
YoY Growth in year ended Mar 2026 is 102.80% vs 204.88% in Mar 2025






